{"title":"心血管疾病患者的综合治疗。新的风险——胰岛素抵抗。卡托普利是首选。来自第63届美国心脏协会科学会议的报告。达拉斯,1990年11月11日]。","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":77137,"journal":{"name":"Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis","volume":"108 ","pages":"1-18"},"PeriodicalIF":0.0000,"publicationDate":"1991-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Comprehensive therapy of the cardiovascularly compromised patient. New risks--insulin resistance. Captopril as choice No. 1. Report from the 63rd scientific meeting of the American Heart Association. Dallas, 11 November 1990].\",\"authors\":\"\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":77137,\"journal\":{\"name\":\"Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis\",\"volume\":\"108 \",\"pages\":\"1-18\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Comprehensive therapy of the cardiovascularly compromised patient. New risks--insulin resistance. Captopril as choice No. 1. Report from the 63rd scientific meeting of the American Heart Association. Dallas, 11 November 1990].